BAKER BROS. ADVISORS LP – Relmada Therapeutics, Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$18.32M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
+94.94%
quarter
Relmada Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 8.92M | $37.02 | 495.11K | |
| Q2 2022 | share | 0.00% | 0 shares | -3.96M | $18.99 | 495.11K | |
| Q1 2022 | share | 0.00% | 0 shares | 2.20M | $26.99 | 495.11K | |
| Q4 2021 | share | Increase | +146.33% | 294.11K shares | 5.88M | $21.71 | 495.11K |
| Q3 2021 | share | Increase | +162.40% | 124.39K shares | 2.81M | $26.21 | 200.99K |
| Q2 2021 | share | Increase | 0.00% | 76.6K shares | 2.45M | $32.01 | 76.6K |